Project Details
Description
? DESCRIPTION (provided by applicant): Hyperglycemia is the major risk factor for the development of diabetic microvascular complications. The ADA recommends lowering the A1c in T2DM individuals to levels (i.e. HbA1c
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/15 → 8/31/18 |
Funding
- National Institutes of Health: $479,984.00
ASJC
- Medicine(all)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.